|
Back to Home » December 2020 News » Sysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity of SafeSEQ NGS Technology for Detection of Measurable Residual Disease in Acute Myeloid Leukemia |
Sysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity of SafeSEQ NGS Technology for Detection of Measurable Residual Disease in Acute Myeloid Leukemia |
December 06, 2020
BALTIMORE, Dec. 5, 2020 /PRNewswire/ -- Sysmex Inostics, Inc., a global leader and pioneer in blood-based, high-sensitivity molecular testing for oncology, is presenting the poster "Ultrasensitive Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML) Using a Targeted...
Source URL: https://www.prnewswire.com:443/news-releases/sysmex-inostics-presents-data-at-the-american-society-of-hematology-annual-meeting-demonstrating-exquisite-sensitivity-of-safeseq-ngs-technology-for-detection-of-measurable-residual-disease-in-acute-myeloid-leu
|
|
|
|
